Study in Brazil demonstrates how the exploration of contextual determinants of distress in mental health care can inform therapeutic change.
While most of the sting is gone, even now — almost sixty years on — I can’t get through a single day without thinking about shock treatment and the state hospital. I regularly have dreams or nightmares about being lost in a strange place and someone making me feel like dirt.
After 25 years of chronic emergency, 22 mental hospitalizations, a stint at a “community mental health center,” 13 years in a "board & care," repeated withdrawals from addictions to legal drugs, and a 12-year marriage, I plan to live every last breath out as a survivor, an advocate, and an artist.
A new study finds that clinicians’ disregard for mental health patients’ insight into their own condition may be detrimental to treatment.
Schizophrenia, to me, is nothing more than a word. All it really means is that you experience psychosis on a regular enough basis that it’s a factor in your life. And that you actually do, as the word “schizophrenia” indicates, have a mind that you share with some sort of outside presence.
Acknowledging the role of trauma inflicted by a given individual’s mother is not the same as laying all blame for “mental illness” at the feet of motherhood. Meanwhile, a mountain of evidence has accumulated linking schizophrenia to sexual, physical, and emotional abuse and many other categories of adverse childhood experiences.
In-depth interviews find that those who screened positive for depression did not explain their experience in terms of diagnostic symptoms.
Millions of current and former foster children experience multiple kinds of trauma, as documented in a six-part investigative series published in the Kansas City Star this month. Too often invisible, these young people deserve our attention and our care.
A new analysis, published in Lancet Neurology, demonstrates how Biogen is spinning results from two failed trials for a new Alzheimer's drug.
Researcher Zel Dolinsky once taught at medical school and worked as a medical writer in the pharmaceutical industry. In his last emails, he told of how the adverse effects of psychiatric drugs led him to choose to end his life.
An anthropological look at the Global Mental Health (GMH) movement suggests several ethical problems and contradictions in its mission.
A network analysis of participants’ social media use and well-being reveals complex links with social capital but a minimal association with attentional control.
Ayahuasca found to be effective in treating moderate to severe depression in low-income population.
A new international study reveals how healthcare providers treat patient’s pain may depend on that patient’s socioeconomic status.
An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).
New research contends that ketamine can reduce problematic alcohol use but does the data support the claims?
Experts across the globe point to the harms of drug companies’ influence on research, practice, and education in healthcare noting that it compromises patient care.
Researchers critically examine the underlying assumptions and implications of a new WHO mental health technology designed to streamline psychiatric assessment internationally.
Antipsychotic drugs are prescribed on the basis of trials that demonstrate a higher rate of ‘relapse’ in people who are withdrawn from these drugs compared to those who continue to take them. Yet, incredibly, there is no consensus about what ‘relapse’ means in this situation.
A new study identifies significant links between food insecurity and sleep, anxiety, depression, and compromised wellbeing among young people in the United States
With deep regret, Mad in America announces another loss in our contributor community. Julie C. Greene, writer and antipsychiatry advocate, lost her battle with kidney disease on November 29 at her home in Beaver Falls, Pennsylvania. Julie had been an MIA blogger since 2014, including several pieces on the dangers of lithium.
A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.
The use of machine learning algorithms (known as artificial intelligence) in the medical field raises a slew of ethical concerns.
Young women’s narratives indicate ways antidepressants have shaped their sense of self.
A closer look at a new study reporting that the supplement D-cycloserine improved anxiety when used with exposure therapy.